vs

Side-by-side financial comparison of MILLER INDUSTRIES INC (MLR) and Tarsus Pharmaceuticals, Inc. (TARS). Click either name above to swap in a different company.

MILLER INDUSTRIES INC is the larger business by last-quarter revenue ($171.9M vs $151.7M, roughly 1.1× Tarsus Pharmaceuticals, Inc.). On growth, Tarsus Pharmaceuticals, Inc. posted the faster year-over-year revenue change (128.4% vs -22.5%). MILLER INDUSTRIES INC produced more free cash flow last quarter ($43.8M vs $13.0M). Over the past eight quarters, Tarsus Pharmaceuticals, Inc.'s revenue compounded faster (134.4% CAGR vs -29.9%).

Miller Industries is an American tow truck and towing equipment manufacturing company based in the Chattanooga suburb of Ooltewah, Tennessee. Its primary subsidiary, Miller Industries Towing Equipment Inc., manufactures a variety of light- to heavy-duty wreckers, car carriers, and rotators under several brand names, including Century, Vulcan, Chevron, and Holmes. Miller Industries also operates international brands with Boniface (U.K.) and Jige (France). It is listed on the New York Stock Exc...

Tarsus Pharmaceuticals, Inc. is a late-stage clinical biopharmaceutical company focused on developing and commercializing innovative therapeutic candidates for unmet medical needs in ophthalmology, dermatology, and other specialty care areas. It operates primarily in the United States, with lead product candidates targeting common, underdiagnosed conditions including demodex blepharitis and rosacea.

MLR vs TARS — Head-to-Head

Bigger by revenue
MLR
MLR
1.1× larger
MLR
$171.9M
$151.7M
TARS
Growing faster (revenue YoY)
TARS
TARS
+150.9% gap
TARS
128.4%
-22.5%
MLR
More free cash flow
MLR
MLR
$30.8M more FCF
MLR
$43.8M
$13.0M
TARS
Faster 2-yr revenue CAGR
TARS
TARS
Annualised
TARS
134.4%
-29.9%
MLR

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
MLR
MLR
TARS
TARS
Revenue
$171.9M
$151.7M
Net Profit
$-8.4M
Gross Margin
15.4%
Operating Margin
2.9%
-5.3%
Net Margin
-5.5%
Revenue YoY
-22.5%
128.4%
Net Profit YoY
63.8%
EPS (diluted)
$0.29
$-0.17

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MLR
MLR
TARS
TARS
Q4 25
$171.9M
$151.7M
Q3 25
$178.7M
$118.7M
Q2 25
$214.0M
$102.7M
Q1 25
$225.7M
$78.3M
Q4 24
$221.9M
$66.4M
Q3 24
$314.3M
$48.1M
Q2 24
$371.5M
$40.8M
Q1 24
$349.9M
$27.6M
Net Profit
MLR
MLR
TARS
TARS
Q4 25
$-8.4M
Q3 25
$3.1M
$-12.6M
Q2 25
$8.5M
$-20.3M
Q1 25
$8.1M
$-25.1M
Q4 24
$-23.1M
Q3 24
$15.4M
$-23.4M
Q2 24
$20.5M
$-33.3M
Q1 24
$17.0M
$-35.7M
Gross Margin
MLR
MLR
TARS
TARS
Q4 25
15.4%
Q3 25
14.2%
Q2 25
16.2%
Q1 25
15.0%
Q4 24
15.1%
Q3 24
13.4%
Q2 24
13.8%
Q1 24
12.6%
Operating Margin
MLR
MLR
TARS
TARS
Q4 25
2.9%
-5.3%
Q3 25
2.4%
-12.2%
Q2 25
5.3%
-21.6%
Q1 25
4.8%
-33.5%
Q4 24
5.7%
-36.8%
Q3 24
6.3%
-52.3%
Q2 24
7.1%
-81.6%
Q1 24
6.1%
-136.5%
Net Margin
MLR
MLR
TARS
TARS
Q4 25
-5.5%
Q3 25
1.7%
-10.6%
Q2 25
4.0%
-19.8%
Q1 25
3.6%
-32.1%
Q4 24
-34.8%
Q3 24
4.9%
-48.7%
Q2 24
5.5%
-81.6%
Q1 24
4.9%
-129.4%
EPS (diluted)
MLR
MLR
TARS
TARS
Q4 25
$0.29
$-0.17
Q3 25
$0.27
$-0.30
Q2 25
$0.73
$-0.48
Q1 25
$0.69
$-0.64
Q4 24
$0.89
$-0.57
Q3 24
$1.33
$-0.61
Q2 24
$1.78
$-0.88
Q1 24
$1.47
$-1.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MLR
MLR
TARS
TARS
Cash + ST InvestmentsLiquidity on hand
$417.3M
Total DebtLower is stronger
$72.4M
Stockholders' EquityBook value
$420.6M
$343.4M
Total Assets
$589.7M
$562.2M
Debt / EquityLower = less leverage
0.21×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MLR
MLR
TARS
TARS
Q4 25
$417.3M
Q3 25
$401.8M
Q2 25
$381.1M
Q1 25
$407.9M
Q4 24
$291.4M
Q3 24
$317.0M
Q2 24
$323.6M
Q1 24
$298.5M
Total Debt
MLR
MLR
TARS
TARS
Q4 25
$72.4M
Q3 25
$72.3M
Q2 25
$72.1M
Q1 25
$72.0M
Q4 24
$71.8M
Q3 24
$71.7M
Q2 24
$71.6M
Q1 24
$29.9M
Stockholders' Equity
MLR
MLR
TARS
TARS
Q4 25
$420.6M
$343.4M
Q3 25
$420.7M
$335.1M
Q2 25
$418.6M
$332.6M
Q1 25
$406.5M
$342.5M
Q4 24
$401.0M
$224.5M
Q3 24
$395.2M
$237.5M
Q2 24
$379.9M
$252.2M
Q1 24
$362.4M
$275.2M
Total Assets
MLR
MLR
TARS
TARS
Q4 25
$589.7M
$562.2M
Q3 25
$604.3M
$534.6M
Q2 25
$622.9M
$495.0M
Q1 25
$639.7M
$500.8M
Q4 24
$667.0M
$377.0M
Q3 24
$755.3M
$376.3M
Q2 24
$748.2M
$376.8M
Q1 24
$696.5M
$349.3M
Debt / Equity
MLR
MLR
TARS
TARS
Q4 25
0.21×
Q3 25
0.22×
Q2 25
0.22×
Q1 25
0.21×
Q4 24
0.32×
Q3 24
0.30×
Q2 24
0.28×
Q1 24
0.11×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MLR
MLR
TARS
TARS
Operating Cash FlowLast quarter
$48.9M
$19.3M
Free Cash FlowOCF − Capex
$43.8M
$13.0M
FCF MarginFCF / Revenue
25.5%
8.6%
Capex IntensityCapex / Revenue
3.0%
4.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$85.0M
$-22.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MLR
MLR
TARS
TARS
Q4 25
$48.9M
$19.3M
Q3 25
$19.9M
$18.3M
Q2 25
$27.2M
$-29.4M
Q1 25
$2.7M
$-20.7M
Q4 24
$-11.7M
$-22.2M
Q3 24
$30.3M
$-8.7M
Q2 24
$-10.7M
$-14.4M
Q1 24
$9.0M
$-37.8M
Free Cash Flow
MLR
MLR
TARS
TARS
Q4 25
$43.8M
$13.0M
Q3 25
$18.1M
$16.3M
Q2 25
$25.6M
$-30.4M
Q1 25
$-2.4M
$-21.2M
Q4 24
$-13.0M
$-22.3M
Q3 24
$24.0M
$-8.9M
Q2 24
$-13.8M
$-15.4M
Q1 24
$4.3M
$-38.0M
FCF Margin
MLR
MLR
TARS
TARS
Q4 25
25.5%
8.6%
Q3 25
10.1%
13.8%
Q2 25
11.9%
-29.6%
Q1 25
-1.1%
-27.1%
Q4 24
-5.9%
-33.5%
Q3 24
7.6%
-18.6%
Q2 24
-3.7%
-37.8%
Q1 24
1.2%
-137.5%
Capex Intensity
MLR
MLR
TARS
TARS
Q4 25
3.0%
4.2%
Q3 25
1.0%
1.6%
Q2 25
0.8%
1.0%
Q1 25
2.3%
0.8%
Q4 24
0.6%
0.1%
Q3 24
2.0%
0.6%
Q2 24
0.8%
2.5%
Q1 24
1.3%
0.6%
Cash Conversion
MLR
MLR
TARS
TARS
Q4 25
Q3 25
6.46×
Q2 25
3.22×
Q1 25
0.34×
Q4 24
Q3 24
1.96×
Q2 24
-0.52×
Q1 24
0.53×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons